Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurema Schmidt

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|February 1, 2019
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor ModulationJulius Pollinger, Leonie Gellrich, Simone Schierle, et al.
Chemmedchem|November 1, 2019
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from ZafirlukastSimone Schierle, Moritz Helmstädter, Jurema Schmidt, et al.
Journal of Medicinal Chemistry|August 29, 2017
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic SteatohepatitisJurema Schmidt, Marco Rotter, Tim Weiser, et al.
Journal of Medicinal Chemistry|June 8, 2018
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed PolypharmacologySimone Schierle, Cathrin Flauaus, Pascal Heitel, et al.
Journal of Medicinal Chemistry|July 28, 2017
Nonacidic Farnesoid X Receptor ModulatorsDaniel Flesch, Sun-Yee Cheung, Jurema Schmidt, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|February 1, 2019
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor ModulationJulius Pollinger, Leonie Gellrich, Simone Schierle, et al.
Chemmedchem|November 1, 2019
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from ZafirlukastSimone Schierle, Moritz Helmstädter, Jurema Schmidt, et al.
Journal of Medicinal Chemistry|August 29, 2017
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic SteatohepatitisJurema Schmidt, Marco Rotter, Tim Weiser, et al.
Journal of Medicinal Chemistry|June 8, 2018
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed PolypharmacologySimone Schierle, Cathrin Flauaus, Pascal Heitel, et al.
Journal of Medicinal Chemistry|July 28, 2017
Nonacidic Farnesoid X Receptor ModulatorsDaniel Flesch, Sun-Yee Cheung, Jurema Schmidt, et al.
Pageof 2